首页> 外国专利> USE OF DANSHENSU, NOTOGINSENOSIDE R1 OR THEIR COMBINATION IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING DISEASES CAUSED BY MICROCIRCULATION DISORDER

USE OF DANSHENSU, NOTOGINSENOSIDE R1 OR THEIR COMBINATION IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING DISEASES CAUSED BY MICROCIRCULATION DISORDER

机译：在预防和治疗微循环障碍所致疾病的药物制备中使用丹参素，三七皂苷R1或其组合

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a new use of traditional Chinese drugproducts ofDanshensu (DLA), Notoginsenoside R1 (R1) and their combination, in particulartothe therapeutic and preventive effects of DLA, R1 and their combination on thediseases caused by microcirculation disorder.

机译：本发明涉及中药的新用途的产品丹参素（DLA），三七皂苷R1（R1）及其组合，尤其是至DLA，R1及其组合对糖尿病的治疗和预防作用微循环障碍引起的疾病。

著录项

公开/公告号CA2781322C

专利类型
公开/公告日2017-04-18

原文格式PDF
申请/专利权人 TIANJIN TASLY PHARMACEUTICAL CO. LTD.;
展开▼

申请/专利号CA20102781322
发明设计人 HAN JINGYAN;GUO JUN;YANG JIYING;SUN KAI;WANG MINGXIA;ZHANG YU;LIU YUYING;
展开▼

申请日2010-11-04
分类号A61K31/192;A61K31/704;A61P1/12;A61P3/06;A61P9/12;A61P11/06;A61P17;A61P17/02;A61P25;A61P31;A61P37/08;A61P43;
国家 CA
入库时间 2022-08-21 13:34:53

相似文献

专利
外文文献
中文文献